CN103257226B - 莱克多巴胺、沙丁胺醇、西马特罗三联胶体金试纸条及其制备方法与用途 - Google Patents
莱克多巴胺、沙丁胺醇、西马特罗三联胶体金试纸条及其制备方法与用途 Download PDFInfo
- Publication number
- CN103257226B CN103257226B CN201310121592.8A CN201310121592A CN103257226B CN 103257226 B CN103257226 B CN 103257226B CN 201310121592 A CN201310121592 A CN 201310121592A CN 103257226 B CN103257226 B CN 103257226B
- Authority
- CN
- China
- Prior art keywords
- cimaterol
- ractopamine
- salbutamol
- monoclonal antibody
- combined
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 229950010971 cimaterol Drugs 0.000 title claims abstract description 94
- 229960002052 salbutamol Drugs 0.000 title claims abstract description 90
- 229940074095 ractopamine Drugs 0.000 title claims abstract description 88
- BUXRLJCGHZZYNE-UHFFFAOYSA-N 2-amino-5-[1-hydroxy-2-(propan-2-ylamino)ethyl]benzonitrile Chemical compound CC(C)NCC(O)C1=CC=C(N)C(C#N)=C1 BUXRLJCGHZZYNE-UHFFFAOYSA-N 0.000 title claims abstract description 81
- NDAUXUAQIAJITI-UHFFFAOYSA-N albuterol Chemical compound CC(C)(C)NCC(O)C1=CC=C(O)C(CO)=C1 NDAUXUAQIAJITI-UHFFFAOYSA-N 0.000 title claims abstract description 78
- YJQZYXCXBBCEAQ-UHFFFAOYSA-N ractopamine Chemical compound C=1C=C(O)C=CC=1C(O)CNC(C)CCC1=CC=C(O)C=C1 YJQZYXCXBBCEAQ-UHFFFAOYSA-N 0.000 title claims abstract description 73
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 title claims abstract description 64
- 238000002360 preparation method Methods 0.000 title claims abstract description 16
- 238000001514 detection method Methods 0.000 claims abstract description 36
- 239000010931 gold Substances 0.000 claims abstract description 35
- 229910052737 gold Inorganic materials 0.000 claims abstract description 35
- 238000012360 testing method Methods 0.000 claims abstract description 22
- 239000000084 colloidal system Substances 0.000 claims abstract description 19
- 239000000020 Nitrocellulose Substances 0.000 claims abstract description 18
- 229920001220 nitrocellulos Polymers 0.000 claims abstract description 18
- 230000000274 adsorptive effect Effects 0.000 claims abstract description 3
- 239000000427 antigen Substances 0.000 claims description 36
- 102000036639 antigens Human genes 0.000 claims description 36
- 108091007433 antigens Proteins 0.000 claims description 36
- 238000000034 method Methods 0.000 claims description 28
- 241000283074 Equus asinus Species 0.000 claims description 7
- 230000003287 optical effect Effects 0.000 claims description 5
- 238000001035 drying Methods 0.000 claims description 4
- 108060003951 Immunoglobulin Proteins 0.000 claims description 2
- 239000003365 glass fiber Substances 0.000 claims description 2
- 102000018358 immunoglobulin Human genes 0.000 claims description 2
- 239000012528 membrane Substances 0.000 claims description 2
- 238000002156 mixing Methods 0.000 claims description 2
- 238000012545 processing Methods 0.000 claims description 2
- 230000003053 immunization Effects 0.000 description 16
- 239000000243 solution Substances 0.000 description 12
- 241000699666 Mus <mouse, genus> Species 0.000 description 11
- 238000003756 stirring Methods 0.000 description 11
- 238000006243 chemical reaction Methods 0.000 description 9
- 238000010790 dilution Methods 0.000 description 9
- 239000012895 dilution Substances 0.000 description 9
- 230000036039 immunity Effects 0.000 description 8
- 238000002965 ELISA Methods 0.000 description 7
- 210000004027 cell Anatomy 0.000 description 7
- 210000004408 hybridoma Anatomy 0.000 description 7
- 239000013642 negative control Substances 0.000 description 7
- 230000015572 biosynthetic process Effects 0.000 description 6
- 235000015097 nutrients Nutrition 0.000 description 6
- 210000002966 serum Anatomy 0.000 description 6
- 238000003786 synthesis reaction Methods 0.000 description 6
- 206010003445 Ascites Diseases 0.000 description 5
- 238000002474 experimental method Methods 0.000 description 5
- 239000001963 growth medium Substances 0.000 description 5
- 238000002649 immunization Methods 0.000 description 5
- 239000007924 injection Substances 0.000 description 5
- 238000002347 injection Methods 0.000 description 5
- 239000000047 product Substances 0.000 description 5
- 230000035945 sensitivity Effects 0.000 description 5
- 210000002700 urine Anatomy 0.000 description 5
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 5
- FALRKNHUBBKYCC-UHFFFAOYSA-N 2-(chloromethyl)pyridine-3-carbonitrile Chemical compound ClCC1=NC=CC=C1C#N FALRKNHUBBKYCC-UHFFFAOYSA-N 0.000 description 4
- 241000699670 Mus sp. Species 0.000 description 4
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 4
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 4
- 239000002671 adjuvant Substances 0.000 description 4
- 239000003814 drug Substances 0.000 description 4
- -1 salbutamol succinic acid derivative Chemical class 0.000 description 4
- 229940014800 succinic anhydride Drugs 0.000 description 4
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- 244000061458 Solanum melongena Species 0.000 description 3
- MUUGCDGGIVCSDT-UHFFFAOYSA-N [NH4+].[NH4+].[O-]S([O-])(=O)=O.CCCCCCCC(O)=O Chemical compound [NH4+].[NH4+].[O-]S([O-])(=O)=O.CCCCCCCC(O)=O MUUGCDGGIVCSDT-UHFFFAOYSA-N 0.000 description 3
- 238000003453 ammonium sulfate precipitation method Methods 0.000 description 3
- 239000002269 analeptic agent Substances 0.000 description 3
- 230000008901 benefit Effects 0.000 description 3
- 238000010367 cloning Methods 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- 238000005516 engineering process Methods 0.000 description 3
- FDWREHZXQUYJFJ-UHFFFAOYSA-M gold monochloride Chemical compound [Cl-].[Au+] FDWREHZXQUYJFJ-UHFFFAOYSA-M 0.000 description 3
- 238000002372 labelling Methods 0.000 description 3
- 239000007788 liquid Substances 0.000 description 3
- NLKNQRATVPKPDG-UHFFFAOYSA-M potassium iodide Chemical compound [K+].[I-] NLKNQRATVPKPDG-UHFFFAOYSA-M 0.000 description 3
- 230000008569 process Effects 0.000 description 3
- 239000006228 supernatant Substances 0.000 description 3
- NHBKXEKEPDILRR-UHFFFAOYSA-N 2,3-bis(butanoylsulfanyl)propyl butanoate Chemical compound CCCC(=O)OCC(SC(=O)CCC)CSC(=O)CCC NHBKXEKEPDILRR-UHFFFAOYSA-N 0.000 description 2
- BVKZGUZCCUSVTD-UHFFFAOYSA-L Carbonate Chemical compound [O-]C([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-L 0.000 description 2
- 102000004190 Enzymes Human genes 0.000 description 2
- 108090000790 Enzymes Proteins 0.000 description 2
- 108010010803 Gelatin Proteins 0.000 description 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 2
- 241001494479 Pecora Species 0.000 description 2
- 206010035226 Plasma cell myeloma Diseases 0.000 description 2
- 206010068676 Pneumoretroperitoneum Diseases 0.000 description 2
- 208000005727 Retropneumoperitoneum Diseases 0.000 description 2
- UCTWMZQNUQWSLP-UHFFFAOYSA-N adrenaline Chemical compound CNCC(O)C1=CC=C(O)C(O)=C1 UCTWMZQNUQWSLP-UHFFFAOYSA-N 0.000 description 2
- 239000007864 aqueous solution Substances 0.000 description 2
- 210000004369 blood Anatomy 0.000 description 2
- 239000008280 blood Substances 0.000 description 2
- 239000007853 buffer solution Substances 0.000 description 2
- 230000010261 cell growth Effects 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- 239000007795 chemical reaction product Substances 0.000 description 2
- 229960001399 clenbuterol hydrochloride Drugs 0.000 description 2
- OPXKTCUYRHXSBK-UHFFFAOYSA-N clenbuterol hydrochloride Chemical compound Cl.CC(C)(C)NCC(O)C1=CC(Cl)=C(N)C(Cl)=C1 OPXKTCUYRHXSBK-UHFFFAOYSA-N 0.000 description 2
- 238000013016 damping Methods 0.000 description 2
- 238000010586 diagram Methods 0.000 description 2
- 238000000502 dialysis Methods 0.000 description 2
- 239000012153 distilled water Substances 0.000 description 2
- 238000004945 emulsification Methods 0.000 description 2
- 230000003203 everyday effect Effects 0.000 description 2
- 239000012530 fluid Substances 0.000 description 2
- 235000013305 food Nutrition 0.000 description 2
- 239000008273 gelatin Substances 0.000 description 2
- 229920000159 gelatin Polymers 0.000 description 2
- 235000019322 gelatine Nutrition 0.000 description 2
- 235000011852 gelatine desserts Nutrition 0.000 description 2
- 230000005764 inhibitory process Effects 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 238000012544 monitoring process Methods 0.000 description 2
- 201000000050 myeloid neoplasm Diseases 0.000 description 2
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 2
- 239000001509 sodium citrate Substances 0.000 description 2
- 210000004988 splenocyte Anatomy 0.000 description 2
- 230000002277 temperature effect Effects 0.000 description 2
- HRXKRNGNAMMEHJ-UHFFFAOYSA-K trisodium citrate Chemical compound [Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O HRXKRNGNAMMEHJ-UHFFFAOYSA-K 0.000 description 2
- 229940038773 trisodium citrate Drugs 0.000 description 2
- 210000003462 vein Anatomy 0.000 description 2
- XWTYSIMOBUGWOL-UHFFFAOYSA-N (+-)-Terbutaline Chemical compound CC(C)(C)NCC(O)C1=CC(O)=CC(O)=C1 XWTYSIMOBUGWOL-UHFFFAOYSA-N 0.000 description 1
- SFLSHLFXELFNJZ-QMMMGPOBSA-N (-)-norepinephrine Chemical compound NC[C@H](O)C1=CC=C(O)C(O)=C1 SFLSHLFXELFNJZ-QMMMGPOBSA-N 0.000 description 1
- QKNYBSVHEMOAJP-UHFFFAOYSA-N 2-amino-2-(hydroxymethyl)propane-1,3-diol;hydron;chloride Chemical compound Cl.OCC(N)(CO)CO QKNYBSVHEMOAJP-UHFFFAOYSA-N 0.000 description 1
- YOETUEMZNOLGDB-UHFFFAOYSA-N 2-methylpropyl carbonochloridate Chemical compound CC(C)COC(Cl)=O YOETUEMZNOLGDB-UHFFFAOYSA-N 0.000 description 1
- JHUUPUMBZGWODW-UHFFFAOYSA-N 3,6-dihydro-1,2-dioxine Chemical compound C1OOCC=C1 JHUUPUMBZGWODW-UHFFFAOYSA-N 0.000 description 1
- 238000011725 BALB/c mouse Methods 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 1
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 1
- 206010015856 Extrasystoles Diseases 0.000 description 1
- 206010019233 Headaches Diseases 0.000 description 1
- 241001529936 Murinae Species 0.000 description 1
- IOVCWXUNBOPUCH-UHFFFAOYSA-M Nitrite anion Chemical compound [O-]N=O IOVCWXUNBOPUCH-UHFFFAOYSA-M 0.000 description 1
- 235000008331 Pinus X rigitaeda Nutrition 0.000 description 1
- 235000011613 Pinus brutia Nutrition 0.000 description 1
- 241000018646 Pinus brutia Species 0.000 description 1
- 229920001030 Polyethylene Glycol 4000 Polymers 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- 240000008042 Zea mays Species 0.000 description 1
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 description 1
- 235000002017 Zea mays subsp mays Nutrition 0.000 description 1
- 238000013019 agitation Methods 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 150000008064 anhydrides Chemical class 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 238000010241 blood sampling Methods 0.000 description 1
- 229910021538 borax Inorganic materials 0.000 description 1
- 238000009395 breeding Methods 0.000 description 1
- 230000001488 breeding effect Effects 0.000 description 1
- 239000000872 buffer Substances 0.000 description 1
- 238000011088 calibration curve Methods 0.000 description 1
- 150000001718 carbodiimides Chemical class 0.000 description 1
- 230000007910 cell fusion Effects 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 238000004587 chromatography analysis Methods 0.000 description 1
- 229960001117 clenbuterol Drugs 0.000 description 1
- STJMRWALKKWQGH-UHFFFAOYSA-N clenbuterol Chemical compound CC(C)(C)NCC(O)C1=CC(Cl)=C(N)C(Cl)=C1 STJMRWALKKWQGH-UHFFFAOYSA-N 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 235000005822 corn Nutrition 0.000 description 1
- 238000010168 coupling process Methods 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 208000002173 dizziness Diseases 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 230000009881 electrostatic interaction Effects 0.000 description 1
- 239000000839 emulsion Substances 0.000 description 1
- 239000003344 environmental pollutant Substances 0.000 description 1
- 230000004927 fusion Effects 0.000 description 1
- 238000007499 fusion processing Methods 0.000 description 1
- 238000004817 gas chromatography Methods 0.000 description 1
- 238000001502 gel electrophoresis Methods 0.000 description 1
- 230000012010 growth Effects 0.000 description 1
- 231100000869 headache Toxicity 0.000 description 1
- 238000004128 high performance liquid chromatography Methods 0.000 description 1
- 210000004754 hybrid cell Anatomy 0.000 description 1
- 230000002209 hydrophobic effect Effects 0.000 description 1
- 230000001900 immune effect Effects 0.000 description 1
- 238000003018 immunoassay Methods 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 238000007689 inspection Methods 0.000 description 1
- 239000007928 intraperitoneal injection Substances 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 235000020997 lean meat Nutrition 0.000 description 1
- 231100000518 lethal Toxicity 0.000 description 1
- 230000001665 lethal effect Effects 0.000 description 1
- 238000004811 liquid chromatography Methods 0.000 description 1
- 229940057995 liquid paraffin Drugs 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 244000144972 livestock Species 0.000 description 1
- 206010025482 malaise Diseases 0.000 description 1
- 238000004949 mass spectrometry Methods 0.000 description 1
- 239000002609 medium Substances 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000011587 new zealand white rabbit Methods 0.000 description 1
- 229940005654 nitrite ion Drugs 0.000 description 1
- 229960002748 norepinephrine Drugs 0.000 description 1
- SFLSHLFXELFNJZ-UHFFFAOYSA-N norepinephrine Natural products NCC(O)C1=CC=C(O)C(O)=C1 SFLSHLFXELFNJZ-UHFFFAOYSA-N 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 231100000719 pollutant Toxicity 0.000 description 1
- 229920001223 polyethylene glycol Polymers 0.000 description 1
- 238000001556 precipitation Methods 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 239000012460 protein solution Substances 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 238000012797 qualification Methods 0.000 description 1
- 238000003908 quality control method Methods 0.000 description 1
- 239000000376 reactant Substances 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 230000002829 reductive effect Effects 0.000 description 1
- 238000002390 rotary evaporation Methods 0.000 description 1
- 239000006152 selective media Substances 0.000 description 1
- 229910052711 selenium Inorganic materials 0.000 description 1
- 239000011669 selenium Substances 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 239000012679 serum free medium Substances 0.000 description 1
- 238000002415 sodium dodecyl sulfate polyacrylamide gel electrophoresis Methods 0.000 description 1
- 235000010339 sodium tetraborate Nutrition 0.000 description 1
- 239000008279 sol Substances 0.000 description 1
- 210000000952 spleen Anatomy 0.000 description 1
- 238000010561 standard procedure Methods 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- 229960000195 terbutaline Drugs 0.000 description 1
- 238000012549 training Methods 0.000 description 1
- IMFACGCPASFAPR-UHFFFAOYSA-N tributylamine Chemical compound CCCCN(CCCC)CCCC IMFACGCPASFAPR-UHFFFAOYSA-N 0.000 description 1
- BSVBQGMMJUBVOD-UHFFFAOYSA-N trisodium borate Chemical compound [Na+].[Na+].[Na+].[O-]B([O-])[O-] BSVBQGMMJUBVOD-UHFFFAOYSA-N 0.000 description 1
- 230000000007 visual effect Effects 0.000 description 1
- 238000011179 visual inspection Methods 0.000 description 1
Landscapes
- Peptides Or Proteins (AREA)
Abstract
Description
Claims (1)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201310121592.8A CN103257226B (zh) | 2013-04-09 | 2013-04-09 | 莱克多巴胺、沙丁胺醇、西马特罗三联胶体金试纸条及其制备方法与用途 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201310121592.8A CN103257226B (zh) | 2013-04-09 | 2013-04-09 | 莱克多巴胺、沙丁胺醇、西马特罗三联胶体金试纸条及其制备方法与用途 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN103257226A CN103257226A (zh) | 2013-08-21 |
CN103257226B true CN103257226B (zh) | 2015-12-09 |
Family
ID=48961261
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201310121592.8A Active CN103257226B (zh) | 2013-04-09 | 2013-04-09 | 莱克多巴胺、沙丁胺醇、西马特罗三联胶体金试纸条及其制备方法与用途 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN103257226B (zh) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103630689B (zh) * | 2013-12-03 | 2015-08-05 | 河北省科学院生物研究所 | 一种检测西马特罗药物残留的酶联免疫试剂盒及其制备方法与应用 |
CN103706331B (zh) * | 2013-12-26 | 2015-10-28 | 南宁市蓝光生物技术有限公司 | 快速纯化富集西马特罗的免疫亲和柱及其制备方法和用途 |
CN108181248A (zh) * | 2017-12-20 | 2018-06-19 | 河南联博生物科技有限公司 | 一种胶乳增强免疫比浊法定量检测沙丁胺醇的试剂 |
CN109061205B (zh) * | 2018-08-09 | 2021-06-08 | 江西中德生物工程股份有限公司 | 检测莱克多巴胺的荧光微球-胶体金双显色定性定量免疫层析试纸条及其制备方法 |
CN109061134B (zh) * | 2018-08-09 | 2021-03-26 | 江西中德生物工程股份有限公司 | 检测沙丁胺醇的荧光微球-胶体金双显色定性定量免疫层析试纸条及其制备方法 |
Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1402004A (zh) * | 2002-09-27 | 2003-03-12 | 江西中德生物工程有限公司 | 一种免疫层析一步法检测β-肾上腺素激动剂类药物的方法及试纸的制备 |
CN101726596A (zh) * | 2009-11-04 | 2010-06-09 | 无锡中德伯尔生物技术有限公司 | 检测乙肝五项的荧光微球免疫层析检测卡及其制备方法 |
CN101915841A (zh) * | 2010-07-26 | 2010-12-15 | 河南省科学院生物研究所有限责任公司 | β-兴奋剂沙丁胺醇、盐酸克伦特罗、莱克多巴胺三元检测测试条及其制备方法 |
CN102230937A (zh) * | 2011-06-17 | 2011-11-02 | 河南省农业科学院 | 瘦肉精多残留联检试纸卡及其制备方法 |
CN202133666U (zh) * | 2011-06-17 | 2012-02-01 | 河南省农业科学院 | 瘦肉精多残留联检试纸卡 |
WO2012129650A1 (en) * | 2011-03-25 | 2012-10-04 | Nanospeed Diagnostics Inc. | Lateral flow immunoassay for detecting vitamins |
-
2013
- 2013-04-09 CN CN201310121592.8A patent/CN103257226B/zh active Active
Patent Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1402004A (zh) * | 2002-09-27 | 2003-03-12 | 江西中德生物工程有限公司 | 一种免疫层析一步法检测β-肾上腺素激动剂类药物的方法及试纸的制备 |
CN101726596A (zh) * | 2009-11-04 | 2010-06-09 | 无锡中德伯尔生物技术有限公司 | 检测乙肝五项的荧光微球免疫层析检测卡及其制备方法 |
CN101915841A (zh) * | 2010-07-26 | 2010-12-15 | 河南省科学院生物研究所有限责任公司 | β-兴奋剂沙丁胺醇、盐酸克伦特罗、莱克多巴胺三元检测测试条及其制备方法 |
WO2012129650A1 (en) * | 2011-03-25 | 2012-10-04 | Nanospeed Diagnostics Inc. | Lateral flow immunoassay for detecting vitamins |
CN102230937A (zh) * | 2011-06-17 | 2011-11-02 | 河南省农业科学院 | 瘦肉精多残留联检试纸卡及其制备方法 |
CN202133666U (zh) * | 2011-06-17 | 2012-02-01 | 河南省农业科学院 | 瘦肉精多残留联检试纸卡 |
Also Published As
Publication number | Publication date |
---|---|
CN103257226A (zh) | 2013-08-21 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN103257226B (zh) | 莱克多巴胺、沙丁胺醇、西马特罗三联胶体金试纸条及其制备方法与用途 | |
CN100482643C (zh) | 一种氨基脲衍生物及其单克隆抗体与应用 | |
CN103575889B (zh) | 一种检测万古霉素的试纸条及方法 | |
CN104693248B (zh) | 肺炎支原体的甘油糖脂抗原 | |
CN102230937A (zh) | 瘦肉精多残留联检试纸卡及其制备方法 | |
CN104017070A (zh) | 一种高灵敏度的多菌灵完全抗原的合成方法 | |
CN104792997A (zh) | 一种人降钙素原免疫检测试剂盒及其制备方法与应用 | |
CN102675463A (zh) | 一种多菌灵单克隆抗体及其制备方法与应用 | |
CN103204927A (zh) | 一种新型隐球菌单克隆抗体的制备方法 | |
CN108918851A (zh) | 一种拉莫三嗪胶体金试纸条的制备方法 | |
CN103333864B (zh) | 抗弓形虫mic3蛋白单克隆抗体及其应用 | |
CN105838681A (zh) | 一株抗地塞米松特异性单克隆抗体杂交瘤细胞株c3及其应用 | |
CN105467115A (zh) | 牛奶中检测黄曲霉毒素m1的免疫层析胶体金试纸条 | |
CN104312978A (zh) | 一种妥布霉素单克隆抗体及其制备方法与应用 | |
EP0142345A2 (en) | Anti-idiotypic vaccine employing anti-idiotypic monoclonal antibodies | |
CN108998424A (zh) | 一株马兜铃酸a单克隆抗体杂交瘤细胞株及其应用 | |
CN103235125A (zh) | 莱克多巴胺、西马特罗二联胶体金试纸条及其制备方法与用途 | |
CN103364546B (zh) | 一种检测呋喃唑酮代谢物的试剂盒及方法 | |
Zhou et al. | Development of a novel antibody probe useful for domoic acid detection | |
CN103105490B (zh) | 一种检测四环素类药物的试剂盒及方法 | |
CN102297964A (zh) | 一种三聚氰胺免疫层析检测试纸条 | |
CN110950962A (zh) | 一株分泌双咪苯脲单克隆抗体的杂交瘤细胞株a11s及其应用 | |
CN102183641A (zh) | 一种莱克多巴胺免疫层析检测试纸条 | |
CN102936584A (zh) | 氨基脲衍生物的单克隆抗体及其应用 | |
CN103207270A (zh) | 西马特罗胶体金试纸条及其制备方法与用途 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
PE01 | Entry into force of the registration of the contract for pledge of patent right |
Denomination of invention: Colloidal gold triple-test strip for ractopamine, salbutamol and cimaterol, and preparation method and application thereof Effective date of registration: 20160615 Granted publication date: 20151209 Pledgee: Bank of Beijing, Limited by Share Ltd, Nanchang branch Pledgor: Zhongde Bio-Engrg Co., Ltd., Jiangxi Registration number: 2016360000008 |
|
PLDC | Enforcement, change and cancellation of contracts on pledge of patent right or utility model | ||
PC01 | Cancellation of the registration of the contract for pledge of patent right | ||
PC01 | Cancellation of the registration of the contract for pledge of patent right |
Date of cancellation: 20170811 Granted publication date: 20151209 Pledgee: Bank of Beijing, Limited by Share Ltd, Nanchang branch Pledgor: Zhongde Bio-Engrg Co., Ltd., Jiangxi Registration number: 2016360000008 |
|
PE01 | Entry into force of the registration of the contract for pledge of patent right |
Denomination of invention: Colloidal gold triple-test strip for ractopamine, salbutamol and cimaterol, and preparation method and application thereof Effective date of registration: 20170811 Granted publication date: 20151209 Pledgee: Bank of Beijing, Limited by Share Ltd, Nanchang branch Pledgor: Jiangxi Sino German bioengineering Limited by Share Ltd Registration number: 2017990000738 |
|
PE01 | Entry into force of the registration of the contract for pledge of patent right | ||
PC01 | Cancellation of the registration of the contract for pledge of patent right |
Date of cancellation: 20180730 Granted publication date: 20151209 Pledgee: Bank of Beijing, Limited by Share Ltd, Nanchang branch Pledgor: Jiangxi Sino German bioengineering Limited by Share Ltd Registration number: 2017990000738 |
|
PC01 | Cancellation of the registration of the contract for pledge of patent right | ||
PE01 | Entry into force of the registration of the contract for pledge of patent right |
Denomination of invention: Colloidal gold triple-test strip for ractopamine, salbutamol and cimaterol, and preparation method and application thereof Effective date of registration: 20180730 Granted publication date: 20151209 Pledgee: Bank of Beijing, Limited by Share Ltd, Nanchang branch Pledgor: Jiangxi Sino German bioengineering Limited by Share Ltd Registration number: 2018990000621 |
|
PE01 | Entry into force of the registration of the contract for pledge of patent right | ||
PC01 | Cancellation of the registration of the contract for pledge of patent right |
Date of cancellation: 20190927 Granted publication date: 20151209 Pledgee: Bank of Beijing, Limited by Share Ltd, Nanchang branch Pledgor: Jiangxi Sino German bioengineering Limited by Share Ltd Registration number: 2018990000621 |
|
PC01 | Cancellation of the registration of the contract for pledge of patent right |